FDA Contracts For QRA Model To Determine Safe Use Levels For 26 Fragrance Allergens

25 Aug 2018

• By Lauren Nardella

The ingredients at issue already must be labeled on cosmetic products in the EU due to their recognized sensitization and allergy potential. FDA expects to award the contract by the end of September, and finished work will be due to the agency within 18 months thereafter.

RS1808_Allergy Stop Sign_214411207_1200.jpg

FDA is taking measures to quantify allergy risks associated with 26 fragrance ingredients, the same set subject to required labeling in the EU when present in concentrations above specified thresholds.

In a notice posted July 23 on the Federal Business Opportunities site fbo.gov, FDA requested contractor proposals for a...